LivaNova Reports Fourth-Quarter and Full-Year 2022 Results :

22.02.2023 - LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023. Fourth-Quarter Financial Summary and Highlights1 ...

Related Keywords

United States , Munich , Bayern , Germany , London , City Of , United Kingdom , Ukraine , Damien Mcdonald , Lang Schwarz , Exchange Commission , Securities Exchange , Livanova United States Inc , Alung Technologies Inc , Heart Valve , Executive Officer , Circulatory Support , Heart Valves , Net Revenue , Excluding Heart Valves , Conference Call , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Annual Reports , Quarterly Reports , Current Reports , States Securities , Livanova United States , Months Ended December , Actual Currency , Constant Currency Rates , Ended December , Excluding Heart , Financial Measures , Three Months Ended December , Year Ended December , Medical Device Regulation , Cash Exchangeable Senior Notes , Term Facilities , Senior Secured Term Loan , Regulatory Costs , Investment Gain , Stockholder Equity , Livanova Stock , Livanova ,